A Double-Blind, Multicenter, Placebo and Active-Controlled, Acute Extension Study of 2 Doses of MK-0869 in the Treatment of Patients With Major Depressive Disorder
Not Applicable
- Conditions
- -F329 Depressive episode, unspecifiedDepressive episode, unspecifiedF329
- Registration Number
- PER-021-02
- Lead Sponsor
- MERCK SHARP & DOHME PERU S.R.L.,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
*Male or female patients who need treatment with antidepressant medications.
*Over 18 years of age.
Exclusion Criteria
* Women who are pregnant or breastfeeding or intend to
get pregnant in the next 12 months
* Contraindication or history of hypersensitivity to paroxetine hydrochloride.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method